fda removes tirzepatide from shortage list 🚨 Alert: No Longer on FDA's Drug As of October 2, 2024, the has announced that the Tirzepatide shortage has been resolved. This means that all doses of Breaking News: Compounding Pharmacies Take

Backed by the landmark STEP and SUSTAIN clinical trial programmes, it has been studied for weight management, blood sugar control, appetite regulation, and cardiovascular health

Call us today to schedule your appointment and get care.

The study is published in...

Novo Nordisk has announced headline results from the STEP UP study, a phase 3b trial in the global STEP programme, which revealed the trial achieved its primary endpoint by demonstrating a statistically significant and superior weight loss at week 72 with semaglutide 7.2mg versus placebo.STEP UP is a 72-week efficacy and safety trial investigating subcutaneous semaglutide 7.2mg compared to semaglutide 2.4mg and placebo, all administered once weekly

And with 30 calories per serving*, theyre well aligned with your nutritional goals

Winter Park FL Tirzepatide for Medical Weight Loss